Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Find ways to tackle frequent budget issues using straightforward methods that fit real life. Start implementing smarter money habits now.
11,741 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Nvidia and Broadcom sit at the heart of AI infrastructure. This guide breaks down which growth stock better fits diff...
In June, the stock market faces a delicate balance between AI excitement and real-world demand. Broadcom’s results sh...
Turnaround stories can create powerful upside for patient investors, but they also open doors for short sellers who b...
At this year’s Fortune COO Summit, a simple question exposed a quiet truth: many COOs hesitate to voice CEO ambitions...
Trading on world prediction markets before kickoff has eclipsed $2 billion, with Spain and France trading as the lead...
A long-term investment thesis centers on a franchise-driven, dividend-growing fast-food operator. The 25-year hold th...
When evaluating telecom stocks, investors ask which is the better telecom stock: verizon versus Rogers. This guide br...
If you’re chasing steady income, the default move isn’t always the highest yield. This guide explains why a dividend ...
Investors are weighing Nvidia's aggressive capital return plans against the durability of its margins and evolving to...
Intel surged about 8% in midday trading, topping gains among the mega-cap chip names. The move comes as investors wei...
Investors are torn between rate hikes and rate cuts as inflation stays stubborn. Wall Street can't decide the Fed's p...